CT-P17 Adalimumab Biosimilar in Patients with Moderate-to-Severe Chronic Plaque Psoriasis: An Open-Label Extension of a Phase 3 Interchangeability Study

• DOI: 10.1007/s13555-025-01383-5
• Publication Date: 2025-03-30T15:58:10Z
• Authors: David M. Pariser; Mark G. Lebwohl; Janusz Jaworski; Jakub Trefler; Stefan Daniluk; Anna Dudek; Wojciech Baran; Witold Owczarek; Pawel Brzewski; Mariusz Sikora; Marek Krogulec; SungHyun Kim; JeeHye Suh; EunJin Choi; JungBin Cha; HyunJin Lee; SungJeong Lee; John Y. Koo
• Keywords: Biosimilar; Post-hoc analysis; Interchangeability